Targeting Abnormal Tau Phosphorylation for Alzheimer's Therapeutics.
Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, Akhtar J, Sheikh S, Vishwakarma VK.
Singh A, et al. Among authors: vishwakarma vk.
Horm Metab Res. 2024 Feb 13. doi: 10.1055/a-2238-1384. Online ahead of print.
Horm Metab Res. 2024.
PMID: 38350636